Cytokine Levels After Consumption of a Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSan™, in Patients with Crohn's Disease and Ulcerative Colitis in a Randomized Single-Blinded Placebo-Controlled Study

Scandinavian Journal of Immunology

Volumn 84, Issue 6, 2016, Pages 323-331

  Therkelsen, S P ^a   Hetland, G ^a,b   Lyberg, T ^a   Lygren, I ^a   Johnson, E ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AGARICUS BLAZEI EXTRACT; AZATHIOPRINE; BUDESONIDE; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESALAZINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACEBO; PREDNISOLONE; TUMOR NECROSIS FACTOR; ANDOSAN; DRUG MIXTURE;

AGARICUS BLAZEI; AGED; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; ULCERATIVE COLITIS; BLOOD; COLITIS, ULCERATIVE; DRUG MIXTURE; PLACEBO EFFECT; THERAPEUTIC USE;

COLITIS, ULCERATIVE; COMPLEX MIXTURES; CROHN DISEASE; CYTOKINES; HUMANS; PLACEBO EFFECT; SINGLE-BLIND METHOD;

EID: 85007005069     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12476     Document Type: Article

References (43)

1. Wasser SP, Weis AL. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol 1999;19:65–96.
2. Lee EW, Shizuki K, Hosokawa S et al. Two novel diterpenoids, erinacines H and I from the mycelia of Hericium erinaceum. Biosci Biotechnol Biochem 2000;64:2402–5.
3. Adachi Y, Okazaki M, Ohno N, Yadomae T. Enhancement of cytokine production by macrophages stimulated with (1–>3)-beta-D-glucan, grifolan (GRN), isolated from Grifola frondosa. Biol Pharm Bull 1994;17:1554–60.
4. Fujimiya Y, Suzuki Y, Katakura R, Ebina T. Tumor-specific cytocidal and immunopotentiating effects of relatively low molecular weight products derived from the basidiomycete, Agaricus blazei Murill. Anticancer Res 1999;19:113–8.
5. Kawagishi H, Kanao T, Inagaki R et al. Formolysis of a potent antitumor (1 → 6)-β-d-glucan-protein complex from Agaricus blazei fruiting bodies and antitumor activity of the resulting products. Carbohydr Polym 1990;12:393–403.
6. Kawagishi H, Nomura A, Yumen T, Mizuno T, Hagiwara T, Nakamura T. Isolation and properties of a lectin from the fruiting bodies of Agaricus blazei. Carbohydr Res 1988;183:150–4.
7. Takaku T, Kimura Y, Okuda H. Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action. J Nutr 2001;131:1409–13.
8. Endo M, Beppu H, Akiyama H et al. Agaritine purified from Agaricus blazei Murrill exerts anti-tumor activity against leukemic cells. Biochim Biophys Acta 2010;1800:669–73.
9. Oh TW, Kim YA, Jang WJ et al. Semipurified fractions from the submerged-culture broth of Agaricus blazei Murill reduce blood glucose levels in streptozotocin-induced diabetic rats. J Agric Food Chem 2010;58:4113–9.
10. Izawa S, Inoue Y. A screening system for antioxidants using thioredoxin-deficient yeast: discovery of thermostable antioxidant activity from Agaricus blazei Murill. Appl Microbiol Biotechnol 2004;64:537–42.
11. Padilha MM, Avila AA, Sousa PJ, Cardoso LG, Perazzo FF, Carvalho JC. Anti-inflammatory activity of aqueous and alkaline extracts from mushrooms (Agaricus blazei Murill). J Med Food 2009;12:359–64.
12. Tsai WJ, Yang SC, Huang YL, Chen CC, Chuang KA, Kuo YC. 4-Hydroxy-17-methylincisterol from Agaricus blazei Decreased Cytokine Production and Cell Proliferation in Human Peripheral Blood Mononuclear Cells via Inhibition of NF-AT and NF-kappaB Activation. Evid Based Complement Alternat Med 2013;2013:435916.
13. Firenzuoli F, Gori L, Lombardo G. The medicinal mushroom Agaricus blazei Murrill: review of literature and pharmaco-toxicological problems. Evid Based Complement Alternat Med 2008;5:3–15.
14. Hetland G, Johnson E, Lyberg T, Kvalheim G. The mushroom Agaricus blazei Murill Elicits medicinal effects on tumor, infection, allergy, and inflammation through its modulation of innate immunity and Amelioration of Th1/Th2 imbalance and inflammation. Adv Pharmacol Sci 2011;2011:157015.
15. Bernardshaw S, Hetland G, Ellertsen LK, Tryggestad AM, Johnson E. An extract of the medicinal mushroom Agaricus blazei Murill differentially stimulates production of pro-inflammatory cytokines in human monocytes and human vein endothelial cells in vitro. Inflammation 2005;29:147–53.
16. Forland DT, Johnson E, Tryggestad AM, Lyberg T, Hetland G. An extract based on the medicinal mushroom Agaricus blazei Murill stimulates monocyte-derived dendritic cells to cytokine and chemokine production in vitro. Cytokine 2010;49:245–50.
17. Liu Y, Zhang L, Zhu X, Wang Y, Liu W, Gong W. Polysaccharide Agaricus blazei Murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune-evasion via the Toll-like receptor 2 pathway. Immunology 2015;146:379–91.
18. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med 2003;197:1107–17.
19. Vetvicka V, Thornton BP, Ross GD. Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J Clin Invest 1996;98:50–61.
20. Ben Nasr A, Haithcoat J, Masterson JE, Gunn JS, Eaves-Pyles T, Klimpel GR. Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria. J Leukoc Biol 2006;80:774–86.
21. Ellertsen LK, Hetland G, Johnson E, Grinde B. Effect of a medicinal extract from Agaricus blazei Murill on gene expression in a human monocyte cell line as examined by microarrays and immuno assays. Int Immunopharmacol 2006;6:133–43.
22. Berven L, Karppinen P, Hetland G, Samuelsen AB. The polar high molecular weight fraction of the Agaricus blazei Murill extract, AndoSan, reduces the activity of the tumor-associated protease, legumain, in RAW 264.7 cells. J Med Food 2015;18:429–38.
23. Grinde B, Hetland G, Johnson E. Effects on gene expression and viral load of a medicinal extract from Agaricus blazei in patients with chronic hepatitis C infection. Int Immunopharmacol 2006;6:1311–4.
24. Johnson E, Forland DT, Saetre L, Bernardshaw SV, Lyberg T, Hetland G. Effect of an extract based on the medicinal mushroom Agaricus blazei murill on release of cytokines, chemokines and leukocyte growth factors in human blood ex vivo and in vivo. Scand J Immunol 2009;69:242–50.
25. Johnson E, Forland DT, Hetland G, Saetre L, Olstad OK, Lyberg T. Effect of AndoSan on expression of adhesion molecules and production of reactive oxygen species in human monocytes and granulocytes in vivo. Scand J Gastroenterol 2012;47:984–92.
26. Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997;18:263–6.
27. Banks C, Bateman A, Payne R, Johnson P, Sheron N. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol 2003;199:28–35.
28. Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut 1989;30:835–8.
29. Woywodt A, Ludwig D, Neustock P et al. Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999;11:267–76.
30. McClane SJ, Rombeau JL. Cytokines and inflammatory bowel disease: a review. JPEN J Parenter Enteral Nutr 1999;23:S20–4.
31. Sato K, Chiba T, Ohkusa T. Serial changes of cytokines in active ulcerative colitis: effects of antibiotic combination therapy. Hepatogastroenterology 2009;56:1016–21.
32. Korolkova OY, Myers JN, Pellom ST, Wang L, M'Koma AE. Characterization of serum cytokine profile in predominantly colonic inflammatory bowel disease to delineate ulcerative and Crohn's colitides. Clin Med Insights Gastroenterol 2015;8:29–44.
33. Forland DT, Johnson E, Saetre L, Lyberg T, Lygren I, Hetland G. Effect of an extract based on the medicinal mushroom Agaricus blazei Murill on expression of cytokines and calprotectin in patients with ulcerative colitis and Crohn's disease. Scand J Immunol 2011;73:66–75.
34. Therkelsen SP, Hetland G, Lyberg T, Lygren I, Johnson E. Effect of a medicinal Agaricus blazei Murill-Based mushroom extract, AndoSan, on symptoms, fatigue and quality of life in patients with ulcerative colitis in a randomized single-blinded placebo controlled study. PLoS ONE 2016;11:e0150191.
35. Therkelsen SP, Hetland G, Lyberg T, Lygren I, Johnson E. Effect of the Medicinal Agaricus blazei Murill-based mushroom extract, AndoSanTM, on symptoms, fatigue and quality of life in patients with Crohn's disease in a randomized single-blinded placebo controlled study. PLoS ONE; 11(7):e0159288. doi: 10.1371/journal.pone.0159288. eCollection 2016.
36. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980;1:514.
37. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989;298:82–6.
38. Dahl J, Ormstad H, Aass HC et al. The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery. Psychoneuroendocrinology 2014;45:77–86.
39. Lima CU, Souza VC, Morita MC, Chiarello MD, Karnikowski MG. Agaricus blazei Murrill and inflammatory mediators in elderly women: a randomized clinical trial. Scand J Immunol 2012;75:336–41.
40. Wang P, Li XT, Sun L, Shen L. Anti-inflammatory activity of water-soluble polysaccharide of Agaricus blazei Murill on Ovariectomized Osteopenic rats. Evid Based Complement Alternat Med 2013;2013:164817.
41. Ellertsen LK, Hetland G. An extract of the medicinal mushroom Agaricus blazei Murill can protect against allergy. Clin Mol Allergy 2009;7:6.
42. Um MY, Park JH, Gwon SY, Ahn J, Jung CH, Ha TY. Agaricus bisporus attenuates dextran sulfate sodium-induced colitis. J Med Food 2014;17:1383–5.
43. Jawhara S, Habib K, Maggiotto F et al. Modulation of intestinal inflammation by yeasts and cell wall extracts: strain dependence and unexpected anti-inflammatory role of glucan fractions. PLoS ONE 2012;7:e40648.